2015Unpublished venueRequires access

General Principles of Pharmacologic Therapy

Zahinoor Ismail, Robert Granger, Bruce G. Pollock

Open publisher page 4 citations

Abstract

This chapter addresses many of the components of clinical pharmacology. Included are pharmacokinetics (PK), pharmacodynamics (PD), pharmacogenomics, and the role of herbal supplements, drugs of abuse, aging, and comorbid medical illness. PD addresses the time course and intensity of drug effects on the body or what the drug does to the body. Variability in PD can exceed that of PK such that similar plasma concentrations can produce different pharmacologic effects in different patients. The chapter discusses the drug-receptor concept, dose-effect relationships, metabolism and its variability, and PD drug interactions. The role of kinetic–dynamic (KD) modeling in clinical pharmacology is reviewed. PD differences are difficult to interpret without concentration data, hence combining PK and PD to address the relationship between concentration and effect is the purpose of KD modeling.

About this research paper

What this paper is about

This chapter addresses many of the components of clinical pharmacology. Included are pharmacokinetics (PK), pharmacodynamics (PD), pharmacogenomics, and the role of herbal supplements, drugs of abuse, aging, and comorbid medical illness. PD addresses the time course and intensity of drug effects on the body or what the drug does to the body. Variability in PD can exceed that of PK such that similar plasma concentrations can produce different pharmacologic effects in different patients. The chapter discusses the drug-receptor concept, dose-effect relationships, metabolism and its variability, and PD drug interactions. The role of kinetic–dynamic (KD) modeling in clinical pharmacology is reviewed. PD differences are difficult to interpret without concentration data, hence combining PK and PD to address the relationship between concentration and effect is the purpose of KD modeling.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter addresses many of the components of clinical pharmacology. Included are pharmacokinetics (PK), pharmacodynamics (PD), pharmacogenomics, and the role of herbal supplements, drugs of abuse, aging, and comorbid medical illness. PD addresses the time course and intensity of drug effects on the body or what the drug does to the body. Variability in PD can exceed that of PK such that similar plasma concentrations can produce different pharmacologic effects in different patients. The chapter discusses the drug-receptor concept, dose-effect relationships, metabolism and its variability, and PD drug interactions. The role of kinetic–dynamic (KD) modeling in clinical pharmacology is reviewed. PD differences are difficult to interpret without concentration data, hence combining PK and PD to address the relationship between concentration and effect is the purpose of KD modeling.

Key concepts: Pharmacogenomics, Pharmacodynamics, Pharmacokinetics, Pharmacology, Clinical pharmacology, Drug, Medicine, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
General Principles of Pharmacologic Therapy — Research Paper | ScholarLens